Non-muscle Invasive Bladder Cancer Therapeutics Market Size to Surpass US$ 9.8 billion at a CAGR of 14.8% between 2023 to 2033| Persistence Market Research
May 11, 2023 09:46 ET
|
Persistence Market Research
New York, May 11, 2023 (GLOBE NEWSWIRE) -- Several cutting-edge cancer treatments available all over the world and a rising need for innovation in cancer treatments led the global non-muscle...
The Home Infusion Therapy Market is Projected To Reach USD 61.7 billion By 2030, From USD 31.94 billion in 2022,Registering a CAGR Of 7.90% During The Forecast Period 2023-2030| Data By Contrive Datum Insights Pvt Ltd.
May 09, 2023 09:09 ET
|
Contrive Datum Insights Pvt Ltd
Farmington, May 09, 2023 (GLOBE NEWSWIRE) -- The Global Home Infusion Therapy Market size was valued at USD 31.94 billion in 2022 and is projected to reach USD 61.7 billion by 2030, growing at a...
Global Filgrastim Biosimilars Market Research Report 2023: Focus on Zarxio, Nivestym, and Releuko
May 02, 2023 06:03 ET
|
Research and Markets
Dublin, May 02, 2023 (GLOBE NEWSWIRE) -- The "Filgrastim Biosimilars Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global filgrastim biosimilars market...
Cancer Pain Management Market Report 2023: Featuring Daiichi Sankyo, Hisamitsu Pharmaceutical, Pfizer, Sanofi & More
April 27, 2023 06:08 ET
|
Research and Markets
Dublin, April 27, 2023 (GLOBE NEWSWIRE) -- The "Cancer Pain Management Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company...
Chemotherapy Drugs Market Insights, Competitive Landscape, and Market Forecasts, 2027
April 13, 2023 10:18 ET
|
Research and Markets
Dublin, April 13, 2023 (GLOBE NEWSWIRE) -- The "Chemotherapy Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2027" drug pipelines has been added to ResearchAndMarkets.com's...
LIXTE Biotechnology Announces Sarah Cannon Research Institute Joins City of Hope’s Ongoing Phase 1b Clinical Trial in Evaluating Lixte’s Lead Anti-Cancer Compound, LB-100, in Small Cell Lung Cancer
April 04, 2023 08:30 ET
|
Lixte Biotechnology Holdings, Inc.
Clinical Trial Focuses on Assessing Whether LB-100 Enhances the Effectiveness of a Standard Regimen Combining Immunotherapy and Chemotherapy for Untreated Small Cell Lung Cancer as it Does in Animal...
Rising Cases of Cancer among Infants to Steer Pediatric Neuroblastoma Treatment Market Past US$ 5.3 Billion by 2033 | Fact.MR Report
March 30, 2023 13:00 ET
|
FACT.MR
Rockville , March 30, 2023 (GLOBE NEWSWIRE) -- Fact.MR – A Market Research and Competitive Intelligence Provider: The global pediatric neuroblastoma treatment market is currently valued at US$ 2.1...
Immune Checkpoint Inhibitors Lead the Bladder Cancer Treatment Drugs Market with US$ 14.8 Billion in Revenue by 2033: Persistence Market Research
March 28, 2023 09:35 ET
|
Persistence Market Research
New York, March 28, 2023 (GLOBE NEWSWIRE) -- As per this new industry analysis by Persistence Market Research, the global Bladder Cancer Treatment Drugs Market was valued at US$ 3.04 billion in 2022...
Retinoblastoma Treatment Global Market Report 2023: Sector to Reach $3.5 Billion by 2028 at a 4.4% CAGR
March 22, 2023 08:43 ET
|
Research and Markets
Dublin, March 22, 2023 (GLOBE NEWSWIRE) -- The "Retinoblastoma Treatment Market by Type, Treatment Type, Type of Staging, Application, and Region 2023-2028" report has been added to ...
Enlivex Receives Positive DSMB Recommendation and IMOH Clearance to Continue Phase I/II Trial of Allocetra combined with chemotherapy in patients with peritoneal metastases arising from solid cancers
March 20, 2023 08:00 ET
|
Enlivex Therapeutics Ltd
Nes-Ziona, Israel, March 20, 2023 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that...